推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 目前，國內(nèi)甘氨酸龍頭企業(yè)紛紛大舉擴產(chǎn)，市場競爭將加劇，勢必導致新一輪的資源整合。在11月15日召開的2014(第四屆)草甘膦產(chǎn)業(yè)綠色發(fā)展高峰論壇上，河北東華冀衡化工有限公司副總經(jīng)理趙忠義預測，甘氨酸市場將進入洗牌階段。
甘氨酸作為草甘膦的主要原料，近年來市場基本保持供需平衡。據(jù)趙忠義介紹，目前甘氨酸國內(nèi)年產(chǎn)量為23—25萬噸，主要用于草甘膦的生產(chǎn)。其中，食品級甘氨酸國內(nèi)年產(chǎn)量為3萬噸，占甘氨酸市場10%，主要以出口為主。
隨著國內(nèi)甘氨酸主要生產(chǎn)企業(yè)，如東華冀衡、東華金龍、東華艦、山東宏泰等企業(yè)紛紛擴產(chǎn)，明年甘氨酸產(chǎn)能預計增加6-8萬噸，總產(chǎn)量將達到30-33萬噸。據(jù)此，趙忠義判斷，在市場不變情況下，甘氨酸將會出現(xiàn)供大于求的局面，市場競爭將加劇，勢必導致新一輪的資源整合。因此，甘氨酸生產(chǎn)企業(yè)要做好迎接挑戰(zhàn)的準備。
